For the first time, the California Institute for Regenerative Medicine has approved a grant for a human clinical trial using embryonic stem cells. The vote to approve the $25 million award represents the institute's decision to move some funding from basic science to research aimed at getting treatments to market.
upper waypoint
lower waypoint
next waypoint
To learn more about how we use your information, please read our privacy policy.